One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Life Science ➤ Pharmaceuticals ➤ Human Growth Hormone Market
Human Growth Hormone Market
Human Growth Hormone Market
Published date: May 2023 • Formats:
Request Sample
  • Home ➤ Life Science ➤ Pharmaceuticals ➤ Human Growth Hormone Market

Global Human Growth Hormone Market By Product (Liquid and Powder), By Indication (Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

  • Published date: May 2023
  • Report ID: 16455
  • Number of Pages: 218
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • Quick Navigation

    • Report Overview
    • Driving Factors
    • Restraining Factors
    • COVID-19 Impact Analysis
    • By Product Analysis
    • By Indication Analysis
    • By Route of Administration Analysis
    • By Distribution Channel Analysis
    • Key Market Segments
    • Growth Opportunity
    • Latest Trends
    • Regional Analysis
    • Key Players Analysis
    • Recent Development
    • Report Scope

    Report Overview

    The global human growth hormone market size is expected to be worth around USD 3.4 Billion by 2022 from USD 7.3 Billion in 2032, growing at a CAGR of 8.1% during the forecast period from 2022 to 2032.

    Human growth hormone, also called somatotropin, is a peptide hormone that stimulates growth. Human growth hormone promotes cell regeneration and reproduction in individuals and other animals. It is, therefore, important in human enlargement. Growth hormone also encourages the production of IGF-1 and increases the concentration of free fatty acids.

    Human growth hormone aids in the management of hormonal imbalance disorders and improves market development. Growth hormone deficiency in humans is initiated when the pituitary gland doesn’t manufacture sufficient focus of human growth hormone. Several genetic diseases, such as Turner syndrome and Parder-Willi syndrome, may similarly cause a growth hormone lack in humans, prominent to hindered puberty and smaller than average height.

    Human Growth Hormone Market

    Driving Factors

    Increasing Incidence of Growth Disorders to Drive the Human Growth Hormone Market Growth

    There has been a steady rise in public understanding regarding the usage of synthetic growth hormone therapy. Owing to the rise in diseases associated with growth hormone deficit, and the increase in usage of raging hormones, determinations are taken by the government and several private organizations to spread consciousness of growth hormone deficiency, and robust efficiency drives the market growth.

    A strong product portfolio and wide R &D activities for the expansion of new growth hormone therapies are anticipated to be the significant factor propelling the market growth. Rising government initiatives are projected to significantly fuel market growth. Additionally, increasing awareness about synthetic growth hormone therapy in emerging countries drives market growth.

    Restraining Factors

    High-Cost of Synthetic Growth Hormone Hamper Market Growth

    The high cost of growth hormone therapies and several side effects related to human growth hormone may hamper the market growth. Stringent rules and regulations for the usage of human growth hormone by athletes and sports specialists are anticipated to hinder the market growth. Economic restrictions faced by developing countries and several obstacles in the market decrease market growth.

    COVID-19 Impact Analysis

    The COVID-19 pandemic is expected to influence the market. Patients with a lack of growth hormone secretion present a risk factor for COVID-19, which need attention that will aid in preventing the COVID-19 outbreak. Also, patients who are suffering from Prader-Willi syndrome also require attention that will benefit the prevention of the COVID-19 pandemic.

    The COVID-19 outbreak has stressed and impacted the healthcare systems around the globe. The global lockdown situation has created difficulties for patients and healthcare providers.

    By Product Analysis

    Powder Segment to Witness Significant Growth

    The global human growth hormone market is segmented into liquid and powder. The powder segment dominated the highest market revenue share of 56.5% in 2022. The most usual process in which growth hormones are provided is in powder form. This growth hormone is in a lyophilized powder form.

    The lyophilized powder is then prepared into suspension with several concentrations in demand to produce growth hormone injectable doses. It helps to regulate composition, body fluids, muscle, and bone growth.

    The liquid segment dominated during the historical period and is estimated to hold the second-largest market share. The great attention of human growth hormone preparation that contains glycine does not have crystallization and is suitable for human growth hormones.

    By Indication Analysis

    The Growth Hormone Deficiency Segment Dominates the Market Growth of the Human Growth Hormone Market

    Based on Indication, the global human growth hormone market is classified into growth hormone deficiency, turner syndrome, Prader-Willi syndrome, and others. The growth hormone deficiency segment accounted for the maximum market revenue share of 35.6% in 2022.

    This can be attributed to the rise in awareness related to the initial detection and treatment of growth hormone deficiency in individuals and the launching of innovative medications for the human growth hormone. It is an endocrine disease categorized by the less excretion of growth hormones.

    The Turner syndrome segment is anticipated to witness the fastest growth rate during the forecast period. Owing to the rising initiatives by several public and private organizations to spread attention about the initial identification and treatment of Turner syndrome.

    Furthermore, this Turner syndrome affects females.  Each year in February, non-profit administrations such as the Turner Syndrome Support Society and Turner Syndrome Foundation notice “Turner Syndrome Awareness Month” and undertake a global movement to increase consciousness of the disease. Human Growth Hormone Market Share

    By Route of Administration Analysis

    The Parenteral Segment Hold the Highest Market Revenue Share During the Forecast Period

    Based on the route of administration, the global human growth hormone market is categorized into parenteral oral and. Among these, the parenteral segment dominated the highest market revenue share in 2022.

    The fact is that when the hormone is injected by parenteral routes, it is mainly absorbed in the cells, which is essential for the patients. Human growth hormone is injected to treat deficiency. The oral segment is anticipated to grow at a CAGR of 5.8%.

    By Distribution Channel Analysis

    The Hospital Pharmacy Segment Dominated the Human Growth Hormone Market

    Based on the distribution channel, the global human growth hormone market is divided into retail pharmacy, hospital pharmacy, and online pharmacy.  Among these, the hospital pharmacy segment registers the highest CAGR during the forecast period.

    Recognized the inclination and comfort of accessibility of artificial human growth hormone in hospital pharmacies. The increasing awareness about growth hormone deficit among individuals and the treatment drives the segment’s growth.

    The online pharmacy segment registers a CAGR of 6.4% in the human growth hormone market due to the high permeation of pharmacies in emerging countries. Further, the rising trend of online pharmacies in developing countries will propel segment growth in the upcoming years.

    Key Market Segments

    By Product

    • Liquid
    • Powder

    By Indication

    • Growth Hormone Deficiency
    • Prader-Willi Syndrome
    • Turner Syndrome
    • Other Indications

    By Route of Administration

    • Oral
    • Parenteral

    By Distribution Channel

    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

    Growth Opportunity

    Increasing Number of Novel Product Approvals

    An increase in the approval of novel product approval and strategic collaboration among key players provides lucrative opportunities for the market. Additionally, a rise in the number of hospital pharmacies will offer significant opportunities for market growth.

    Owing to the rising compliance for the treatments of growth hormone-related disorders and a big untapped market in emerging countries offer high revenue generation opportunities in the developed regions. Due to their wide populations, India and China are becoming key opportunity areas for the healthcare industry in the upcoming years.

    Latest Trends

    Increasing Trend of Online Pharmacies in Developing Regions is the Global Trends in the Market

    The increasing number of online pharmacies in developed regions such as the US and Europe is the trend in the global human growth hormone market. An increase in the prevalence of growth hormone deficiency drives market growth. Human growth hormone is used for the treatment of several medical conditions, such as Turner syndrome, growth hormone deficiency, and chronic kidney disease. Synthetic human growth hormone is available in most counties without a doctor’s prescription.

    Regional Analysis

    North America Dominates the Global Human Growth Hormone Market During the Forecast Period

    North America accounted for a significant human growth hormone market revenue share of 37.4%. Owing to the variations such as favorable reimbursement policies, established healthcare infrastructure, and expanding healthcare consciousness.

    Further, rising access to inventive pharmaceuticals as a result of the presence of important firms in the region helps the US market. The increase in the geriatric population and the presence of various market giants dominated the North American market.

    The Asia-Pacific market is anticipated to hold the maximum revenue share during the forecast period. Market players are focusing on obtaining a significant share in potential countries of the APAC, such as China and Japan, by obtaining adoption and introduction of new products.

    Human Growth Hormone Market Regional Analysis

    Key Regions

    • North America
      • The US
      • Canada
      • Mexico
    • Western Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Portugal
      • Ireland
      • Austria
      • Switzerland
      • Benelux
      • Nordic
      • Rest of Western Europe
    • Eastern Europe
      • Russia
      • Poland
      • The Czech Republic
      • Greece
      • Rest of Eastern Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Australia & New Zealand
      • Indonesia
      • Malaysia
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Colombia
      • Chile
      • Argentina
      • Costa Rica
      • Rest of Latin America
    • Middle East & Africa
      • Algeria
      • Egypt
      • Israel
      • Kuwait
      • Nigeria
      • Saudi Arabia
      • South Africa
      • Turkey
      • United Arab Emirates
      • Rest of MEA

    Key Players Analysis

    The human growth hormone market is highly developed, with the presence of many international and domestic key players key operating in the market. This market player is experiencing strategic developments in order to remain competitive and obtain a significant market share. Various companies are focusing on developing long-acting human growth hormones.

    The main companies are operating various strategies such as new product launches and collaborations. Some of the prominent key players in the human growth hormone market include Novartis AG, Merck KGaA, Pfizer Inc., Ferring B.V., Eli Lily and Company, and other key players.

    Top Key Players

    • Novartis AG
    • Merck KGaA
    • Pfizer Inc.
    • Ferring B.V.
    • Genetech Inc.
    • Eli Lily and Company
    • Novo Nordisk A/S
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Other Key Players

    Recent Development

    • February 2021-Pfizer Inc. and OPKO Health Inc. introduce that the European Medicines Agency has accepted Somatrogon for the cure of juvenile growth hormone deficiency patients.
    • August 2021- Ascendis Pharma received Food and Drug Administration approval for their SKYTROFA injectable in August. These products will be released in the whole market, approving the corporation to make major revenue.

    Report Scope

    Report FeaturesDescription
    Market Value (2022)US$ 3.4 Bn
    Forecast Revenue (2032)US$ 7.3 Bn
    CAGR (2023-2032)8.1%
    Base Year for Estimation2022
    Historic Period2016-2022
    Forecast Period2023-2032
    Report CoverageRevenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments CoveredBy Product- Liquid, Powder; By Indication- Growth Hormone Deficiency, Prader-Willi Syndrome, Turner Syndrome, Other Indications; By Route of Administration- Oral and Parenteral; By Distribution Channel- Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
    Regional AnalysisNorth America – The US, Canada, & Mexico; Western Europe – Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe – Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC – China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America – Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; The Middle East & Africa – Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA
    Competitive LandscapeNovartis AG, Merck KGaA, Pfizer Inc., Ferring B.V., Genetech Inc., Eli Lily and Company, Novo Nordisk A/S, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Other Key Players
    Customization ScopeCustomization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase OptionsWe have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)

     

    Frequently Asked Questions (FAQ)

    What is the size of human growth hormone market?

    The global human growth hormone market size is expected to be worth around USD 3.4 Billion by 2022 from USD 7.3 Billion in 2032.

    What will be the CAGR of global human growth hormone market?

    The global human growth hormone market is poised to grow at a CAGR of 8.1% from 2023 to 2032.

    Who are the prominent players operating in the human growth hormone market?

    Novartis AG, Merck KGaA, Pfizer Inc., Ferring B.V., Genetech Inc., Eli Lily and Company, Novo Nordisk A/S, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Other Key Players ,

    Human Growth Hormone Market
    Human Growth Hormone Market
    Published date: May 2023
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Novartis AG Company Profile
    • Merck KGaA Company Profile
    • Pfizer Inc Company Profile
    • Ferring B.V.
    • Genetech Inc.
    • Eli Lily and Company
    • Novo Nordisk A/S Company Profile
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd. Company Profile
    • Other Key Players
  • settingsSettings

Related Reports

  • Electrification Market
  • Aesthetic Implants Market
  • Sexually Transmitted Disease Market
  • Clinical Nutrition Market
  • Single-Cell Multiomics Маrkеt
  • Real Time Location Systems in Sports Market

Our Clients

  • Our Clients
Inquiry Before Buying

Human Growth Hormone Market
  • 16455
  • May 2023
    • ★★★★★
      ★★★★★
    • (45)
  • US $5,999
    US $2,999
  • US $7,999
    US $3,499
  • US $12,999
    US $4,499
Buy Now
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$5,999
$2,999
USD / per unit
save 50%
Multi User
$7,999
$3,499
USD / per unit
save 55%
Corporate User
$12,999
$4,499
USD / per unit
save 65%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 2,999)Buy Now ($ 3,499)Buy Now ($ 4,499)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library
Secured Payment Options
Secured Payment Options

© 2023 Market.Us. All Rights Reserved.